The recognition of peptide-MHC (pMHC) complexes by T cells is the cornerstone of cellular immunity, enabling the elimination of infected or tumoral cells. pMHC can thus be leveraged as a detection tool for T cells.
Researchers at Stanford University have discovered a first-in-class covalent inhibitor that binds to activated Fis1 and prevents mitochondrial fission and dysfunction.
Stanford researchers have designed a new type of reactor that uses magnetic induction instead of fossil fuel combustion to enable even distribution of high-grade heat for thermochemical processing.
Researchers at Stanford have developed fully genetically-encodable lysosome-targeting chimeras which allow for the targeted delivery of various proteins into receiver cells.
Researchers at Stanford have developed fusion proteins, containing ACE2 domain linked to a fragment of non-neutralizing anti-SARS-CoV-2 spike protein antibody, with a greater breadth of protection than previously described similar fusion proteins.
Stanford researchers have engineered hematopoietic stem cells to provide long-term secretion of chosen therapeutic antibodies, eliminating the need of repeated dosing for delivery.
Stanford scientists have discovered that the untranslated region (UTR) of RNA can be engineered into autonomous switches capable of both sensing native biological conditions (e.g.
Stanford scientists have developed a method that utilizes specialized microbes to capture and convert dilute atmospheric carbon dioxide into reduced organic compounds.
Researchers in the Stanford School of Sustainability have patented a sustainable, cost-effective, scalable subsurface energy storage system with the potential to revolutionize solar thermal energy storage by making solar energy available 24/7 for a wide range of industrial app
Industry, government, and private investment in CO2 capture is growing to address climate change. Without carbon utilization, however, high costs impede large scale capture efforts.
Researchers in Dr. Michelle Monje-Deisseroth's lab at Stanford have identified therapeutic targets for drug development to limit the spread of high-grade gliomas (HGGs).
Researchers in the Airan Lab have developed a noninvasive method using low intensity transcranial ultrasound to drive cerebrospinal fluid (CSF) glymphatic and lymphatic flow to clear brain injury waste products from CSF and brain interstitium.
Stanford researchers have developed a predictive biomarker for hepatocellular carcinoma (HCC) recurrence post-treatment that provides key spatial distribution information about cell interaction.